16:33 - 29.07.2021

---

July 29, Fineko/abc.az. American pharmaceutical company Pfizer has raised the forecast of sales revenue that they will receive this year from vaccine against a new type of coronavirus (Covid-19), developed by German company BioNTech, from $26 bn up to $33.5 bn.

ABC.AZ reports that in May Pfizer announced that it plans to earn $26 bn this year from sales of vaccines.

According to the company, Pfizer's revenue in the 2nd quarter of this year (Apr-Jun) increased by 92% (versus same term of 2020) up to $19 bn.

Company's sales for the same period of 2020 amounted to $9.9 bn.